Pharma Giants Halt Investments in Germany Citing Berlin's Austerity Measures; Government Defends Course

Pharmaceutical companies Boehringer Ingelheim and Eli Lilly have announced a halt to significant investments in Germany, citing austerity directives from Berlin. The German government has since defended its fiscal policies in response to the companies' decisions.